Markets
BSE See NSE See 31,028.21
278.18 (0.9%)
collapse Related Readings collapse

Aurobindo Pharma Gets USFDA Approval For Generic Diovan HCT

By Shrikant Akolkar | 3/22/2013 3:42 PM Friday

Aurobindo Pharma has reported receiving final approval for the Valsartan and Hydrochlorothiazide tablets (brand name Diovan HCT held by Novartis). The drug is indicated in the treatment of hypertension to lower blood pressure. The market size of this drug is USD 1.7 billion (Rs 9350 crore) as per the company’s BSE filings. Aurobindo has said that the product is ready for launch and that this will happen soon.

Drug major Mylan has already launched an authorised generic version of this drug in USA. We believe that Aurobindo is the first to launch the generic of this drug considering that Mylan’s was an authorised generic.

We spoke to the company spokesperson, who declined to comment on the pricing and market share of the drug. However, he did say that the company expects to see about 3-4 generic players in the market. Considering this, about 20% market share looks achievable for Aurobindo. Since it is the first to launch, there would not be a massive erosion of price initially. However, as the drug has already fallen out of patent cover, new players would try to enter the market as faster as possible. Once other companies start launching their versions of the drug, the price will go down.

Considering 80% price erosion and 10% market share for Aurobindo, it can be estimated that the company may achieve revenues of about Rs 700 crore from the drug. Of course, these numbers are based on the assumption that the company makes the best of this opportunity.

With this approval, Aurobindo Pharma has a total of 181 ANDA approvals from USFDA, of which 156 are final and 25 are tentative approvals.

 

Find More Articles on: Markets, DSIJ Mindshare, Product, Large Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ
Mindshare

Q4FY17 Results:Indian Hotels Company

Q4FY17 Results:Indian Hotels Company

Indian Hotels reported its results for the quarter ended March 31, 2017 on Friday.Total sales for this quarter, Q4FY17, came in at Rs. 707 crore. This represents a 1.73 per cent sequential increase and 3.21 per cent YoY increase.

Overnight Digest: Stocks to look out for on May 29

Overnight Digest: Stocks to look out for on May 29

The stocks which are expected to witness significant movements on May 29 are Punj Lloyd, Jaypee Infratech, Adani Power and Adani Enterprises.

Q4FY17 Results: SKF India Ltd.

Q4FY17 Results: SKF India Ltd.

SKF India Ltd reported its results for the quarter ended March 31, 2017 today.

Q4FY17 Results: Sun Pharmaceuticals Ltd

Q4FY17 Results: Sun Pharmaceuticals Ltd

Sun Pharmaceuticals Ltd, the fifth largest speciality generic pharma company, reported its results for the quarter ended March 31, 2017 today.

Q4FY17 Results: Eros International Media

Q4FY17 Results: Eros International Media

Eros International Media reported its results for the quarter ended March 31, 2017 on Friday.

Tech Mahindra Ltd.: Q4FY17 Results

Tech Mahindra Ltd.: Q4FY17 Results

The company's total sales for Q4FY17 came in at Rs 7495 crore, which represents a 0.83 per cent sequential decline and 8.88 per cent YoY increase.

National Buildings Construction Corporation Limited : Q4FY17 Results

National Buildings Construction Corporation Limited : Q4FY17 Results

The company's total sales for Q4FY17 came in at Rs 2356 crore, which represents a 65.22 per cent sequential increase and 2.3 per cent YoY increase.

Indian markets create yet another history; Nifty, Sensex touch fresh highs

Indian markets create yet another history; Nifty, Sensex touch fresh highs

It was party time on D-Street as markets rocked on a memorable day. Indian equity markets on Friday achieved their lifetime highs.

Birla Corporation : Q4FY17 Result

Birla Corporation : Q4FY17 Result

Its operating profit (EBIT) for the quarter amounted to Rs. 59.5 crore and its EBIT margin stood at 6.4 per cent.

Q4FY17 Results: ITC Ltd

Q4FY17 Results: ITC Ltd

ITC Ltd reported its results for the quarter ended March 31, 2017 today.

Market
CHIT CHAT

What is your view on markets today?

200  Characters Remaining.
Please LOGIN  to post your comments or Click here to go back.
SHIBANANDA SEN May 26 05:56PM
in the tracker screen what the 3rd col stands for & the meaning of B
Ronak Maloo May 26 03:56PM
Signing off for the weekednf.Happy Weekend Guys!
DIVYANSH SHUKLA May 26 03:31PM
HUDCO sell target 73.2
Souvik Sengupta May 26 03:27PM
Wabco check
Ronak Maloo May 26 03:18PM
SORT CADILA